Healthcare -
Biotechnology - NASDAQ - US
$ 48.435
7.68 %
$ 3.15 B
Market Cap
-15.32
P/E
KYMR - REVENUE
Revenue KYMR - Kymera Therapeutics, Inc.
47.1 M
LAST VALUE
0.26%
2 YEAR CAGR
74.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR